Boston Scientific Pre-Tax Profit Margin 2010-2023 | BSX
Current and historical pre-tax profit margin for Boston Scientific (BSX) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Boston Scientific pre-tax profit margin for the three months ending December 31, 2023 was .
| Boston Scientific Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $14.24B | $1.99B | 13.94% |
| 2023-09-30 | $13.76B | $1.88B | 13.63% |
| 2023-06-30 | $13.40B | $1.51B | 11.27% |
| 2023-03-31 | $13.05B | $1.43B | 10.95% |
| 2022-12-31 | $12.68B | $1.14B | 9.00% |
| 2022-09-30 | $12.57B | $0.87B | 6.88% |
| 2022-06-30 | $12.33B | $1.10B | 8.95% |
| 2022-03-31 | $12.16B | $0.91B | 7.46% |
| 2021-12-31 | $11.89B | $1.08B | 9.05% |
| 2021-09-30 | $11.47B | $1.26B | 11.02% |
| 2021-06-30 | $11.20B | $0.55B | 4.95% |
| 2021-03-31 | $10.12B | $0.22B | 2.21% |
| 2020-12-31 | $9.91B | $-0.08B | -0.80% |
| 2020-09-30 | $10.11B | $-0.39B | -3.88% |
| 2020-06-30 | $10.16B | $-0.07B | -0.73% |
| 2020-03-31 | $10.79B | $0.25B | 2.34% |
| 2019-12-31 | $10.74B | $0.69B | 6.40% |
| 2019-09-30 | $10.39B | $0.99B | 9.52% |
| 2019-06-30 | $10.08B | $1.35B | 13.44% |
| 2019-03-31 | $9.94B | $1.56B | 15.66% |
| 2018-12-31 | $9.82B | $1.42B | 14.48% |
| 2018-09-30 | $9.67B | $1.35B | 14.00% |
| 2018-06-30 | $9.50B | $1.21B | 12.71% |
| 2018-03-31 | $9.27B | $0.95B | 10.26% |
| 2017-12-31 | $9.05B | $0.93B | 10.31% |
| 2017-09-30 | $8.83B | $0.79B | 8.99% |
| 2017-06-30 | $8.71B | $0.74B | 8.52% |
| 2017-03-31 | $8.58B | $0.25B | 2.96% |
| 2016-12-31 | $8.39B | $0.18B | 2.11% |
| 2016-09-30 | $8.17B | $-0.25B | -3.05% |
| 2016-06-30 | $7.96B | $-0.87B | -10.97% |
| 2016-03-31 | $7.67B | $-0.37B | -4.84% |
| 2015-12-31 | $7.48B | $-0.65B | -8.69% |
| 2015-09-30 | $7.39B | $-0.87B | -11.74% |
| 2015-06-30 | $7.34B | $-0.50B | -6.77% |
| 2015-03-31 | $7.37B | $-0.71B | -9.57% |
| 2014-12-31 | $7.38B | $-0.51B | -6.90% |
| 2014-09-30 | $7.33B | $0.10B | 1.42% |
| 2014-06-30 | $7.22B | $0.06B | 0.84% |
| 2014-03-31 | $7.16B | $0.32B | 4.43% |
| 2013-12-31 | $7.14B | $-0.22B | -3.12% |
| 2013-09-30 | $7.13B | $-0.23B | -3.24% |
| 2013-06-30 | $7.13B | $-0.85B | -11.99% |
| 2013-03-31 | $7.14B | $-4.62B | -64.73% |
| 2012-12-31 | $7.25B | $-4.11B | -56.66% |
| 2012-09-30 | $7.28B | $-4.06B | -55.76% |
| 2012-06-30 | $7.42B | $-3.28B | -44.28% |
| 2012-03-31 | $7.56B | $0.49B | 6.51% |
| 2011-12-31 | $7.62B | $0.64B | 8.42% |
| 2011-09-30 | $7.78B | $0.77B | 9.93% |
| 2011-06-30 | $7.82B | $0.82B | 10.54% |
| 2011-03-31 | $7.77B | $0.79B | 10.10% |
| 2010-12-31 | $7.81B | $-1.06B | -13.62% |
| 2010-09-30 | $7.88B | $-2.64B | -33.49% |
| 2010-06-30 | $7.99B | $-2.85B | -35.62% |
| 2010-03-31 | $8.14B | $-2.79B | -34.23% |
| 2009-12-31 | $8.19B | $-1.31B | -15.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $109.225B | $14.240B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |